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bstract
Cancer chemoprevention involves the application of natural or synthetic compounds to reduce the risk of cancer development. One of the most
ffective strategies for preventing human cancers might involve inducing phase II detoxifying enzymes and antioxidant enzymes via  natural dietary
ompounds. The regulatory regions of these inducible genes encode the antioxidant response element (ARE). Nuclear factor-erythroid 2-related
actor 2 (Nrf2), as a transcription factor, plays a key role in the expression of ARE-mediated genes. Similarly, Nrf2 performs an essential function
n the up-regulation of these genes in response to oxidative stress and treatment with dietary phytochemicals. In this article, we discuss the current
tate of knowledge regarding the Nrf2/ARE pathway as a potential molecular target for cancer chemoprevention and its molecular regulation
echanisms, and highlight Nrf2/ARE inducers derived from natural products, which may be used as chemopreventive agents for cancer patients.
 2013 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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s.  Introduction
Tumorigenesis is a multiple-stage and multiple-factor pro-
ess, typically divided into three stages, including initiation,
romotion and progression [1]. Despite extensive global
esearch aimed at ameliorating the dismal outcomes of can-
ers, no obvious decline in the overall mortality rate of most
ancers has been observed in the past 30 years. During this
ame period, chemoprevention has gained much attention as a
ealistic strategy to fight against cancers. Emerging evidence
as shown that phytochemicals in vegetables and fruits may
erve as potential chemopreventive agents that also have the
dvantage of exhibiting relatively low toxicity, low cost, and
re recognized as important components of healthy foods [2].∗ Corresponding author at: The Cancer Institute of New Jersey, 195 Little
lbany Street, New Brunswick, NJ 08903, USA.
E-mail address: nchen510@gmail.com (N. Chen).
1 These authors contributed equally to this work.
eer review under responsibility of Beijing Academy of Food Sciences.
213-4530 © 2013 Beijing Academy of Food Sciences. Production and
osting by Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.fshw.2013.01.001
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These phytochemicals have also been linked with the induc-
ion of cellular defense detoxifying/antioxidant enzymes, but
ore importantly, dietary phytochemicals can induce apoptotic
ell death in pre-neoplastic or neoplastic cells through differ-
nt growth inhibitory mechanisms, including the activation of
ytochrome C (Cyt C)/caspase and cell cycle arrest, and the
nhibition of nuclear factor-B (NF-B), Janus kinase (JAK)-
ignal transducer and activator of transcription (STAT) signaling
athways, resulting in the inhibition of tumor progression [3,4].
Nuclear factor-erythroid 2-related factor 2 (Nrf2), a mem-
er of the Cap “n” collar (CNC) family of basic region-leucine
ipper (bZIP) proteins, plays an important role in mediating
RE-dependent gene expression [5]. In addition, previous find-
ngs have demonstrated that Nrf2 is an important modulator of
usceptibility to carcinogen-induced carcinogenesis. The cyto-
rotective role of activated Nrf2 has been demonstrated in the
usceptibility of Nrf2 knockout mice to cancers [6]; therefore,
he activation of Nrf2 signaling and the induction of its tar-
et genes identify it as an important pharmacological target
or cancer prevention. In addition, many phytochemicals are
trong activators of Nrf2, thus they regulate the defense enzymes
hrough the activated Nrf2 signaling pathway. Evidence contin-
es to accumulate from both experimental and epidemiological
tudies demonstrating the significance of natural products in
hemoprevention, which suggests that daily consumption is a
romising new approach in the prevention of carcinogenesis.
his review summarizes the current knowledge related to the
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olecular mechanisms of Nrf2 regulation, and highlights the
rotective role of natural products in cancer chemoprevention
ia induction of the Nrf2–ARE-axis signaling pathway.
.  Cytoprotective  enzymes  regulated  by  Nrf2
Nrf2, also described in the literature as NF-E2 related
actor-2, is a bZIP protein encoded by the nuclear factor
erythroid-derived 2)-like2 (NFE2L2) gene. NFE2L2 contains
onserved JUN and FOS regions that function to form the acti-
ator protein-1 (AP-1) transcription factor for mediating various
ellular processes associated with cell differentiation, prolifera-
ion and apoptosis [7–9].
Under basal resting conditions, Nrf2 appears to be associated
ith the repressor Kelch-like ECH-associated protein (Keap1)
s an inactive Nrf2–Keap1 complex, subsequently preventing
rf2 from entering into the nucleus. After translocation into
he nucleus, Nrf2 binds to the antioxidant response element
ARE) of ARE-target genes, which leads to the enhanced expres-
ion of phase II detoxifying/antioxidant enzymes. Nrf2 protein
s an important transcription factor responsible for stimulating
he transcription of cytoprotective genes in response to oxida-
ive or electrophilic stress. This process involves the binding of
rf2 with Maf protein in the nucleus to form a heterodimer,
ubsequently interacting with AREs to activate gene transcrip-
ion [5,10]. Downstream genes transcribed by Nrf2 may be
ategorized as intracellular redox balancing proteins, phase II
etoxifying enzymes, or transporters responsible for the removal
f harmful endogenous substances [11]. Redox balancing pro-
eins are responsible for reducing the levels of reactive oxygen
pecies (ROS), thioredoxin (Trx), thioredoxin reductase (TrxR),
eroxiredoxin (Prx), glutamate cysteine ligase (GCL), and heme
xygenase-1 (HO-1); while the phase II detoxifying enzymes are
esponsible for metabolizing xenobiotics or increasing xeno-
iotic solubility to facilitate the removal of glutathione S
ransferase (GST), UDP-glucuronosyltransferase (UGT), and
AD(P)H:quinone oxidoreductase-1 (NQO1) [11,12]. There-
ore, Nrf2 and its downstream genes not only guard against
xidative and electrophilic insults, but also prevent the devel-
pment of cancers [13,14]. How Nrf2 and ARE-regulated genes
revent the development of cancers will be discussed in the
ollowing sections.
.  Regulation  of  Nrf2  activation
The core of the Nrf2 regulation is Keap1. Keap1 functions
s a negative regulator of Nrf2 by promoting ubiquitination and
roteasomal degradation of Nrf2 [15]. Since Keap1 has highly
eactive sulfhydryl groups in its cysteine residues, it is consid-
red as a sensor for electrophilic compounds including heavy
etals and chemopreventive agents. Many xenobiotics undergo-
ng oxidative metabolism can interact with thiol residues present
n the functionally critical motifs of different proteins. Nuclear
ccumulation and activation of Nrf2 involves the alteration of
eap1 structure by oxidation or covalent modification of critical
ysteine residues in Keap1 [16]. At present, two general mech-
nisms have been proposed to explain nuclear accumulation of
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rf2 in response to inducers. The first is the down-regulation of
rf2 ubiquitination. The second mechanism involves the alter-
tion of the nuclear import/export of Nrf2 [17]. At least one
revious study has reported that a compound with high electron
ithdrawing potency could also function as an Nrf2 activator
hrough the modification of cysteine residues in Keap1 [18].
or example, sulforaphane can form the thionoacyl adduct of
ulforaphane–Keap1 and modify the tertiary structure of Keap1
ost readily at the cysteine residues localized at the Kelch
omain, thereby to stabilize Nrf2 [19]. This suggests that the
election of compounds that do not induce cellular toxicity and
re capable of modifying the structure and function of Keap1
ay provide important clues for the development of therapeuti-
ally applicable drugs targeting Nrf2.
In addition to covalent modification of thiol groups in Keap1,
he activation of protein kinase signaling pathways including
rotein kinase C, mitogen activated protein kinases (MAPKs),
hosphatidylinositol 3-kinase (PI-3K), ER-localized pancreatic
ndoplasmic reticulum kinase (PERK) or casein kinase 2 (CK2),
an also phosphorylate Nrf2, thus they can affect the release
rocess of Nrf2 from the Nrf2–Keap1 complex as well as the
tability and nuclear translocation of Nrf2. Research to date has
uggested that the phosphorylation of Nrf2 serine and threonine
esidues by the above-listed kinases may be potentially involved
n Nrf2-mediated signal transduction at AREs [20–23]. Pre-
ious studies have reported that PKC directly phosphorylates
rf2 at serine 40, thereby promoting the dissociation of Nrf2
rom Keap1 [24,25]. Nrf2 may also be activated by MAPKs.
n MAPKs, ERK and JNK appear to enhance Nrf2 signaling
athways through the recruitment and phosphorylation of trans-
riptional co-activators such as p300 and PBP [26]. In contrast,
38MAPK may either stimulate or inhibit the nuclear translo-
ation of Nrf2 depending on cell types [27,28]. Several other
tudies have indicated that the activation of PI-3K signaling
ascades results in the activation of Nrf2 [29,30]. Moreover,
rf2 can be a substrate for PERK that phosphorylates Nrf2
23], and then enhances its nuclear translocation by disrupting
eap1 binding [23]. Furthermore, the phosphorylation of Nrf2
y CK2 is also a critical controlling factor in Nrf2 activity and
egradation [31].
.  Potential  natural  chemopreventive  agents
As mentioned above, the activation of the Nrf2 signaling path-
ay governs the expression of ARE-driven genes, and dietary
hemopreventive compounds function as detoxifying enzyme
nducers. For example, phase II detoxification and antioxi-
ant enzymes act against carcinogenic insults. Currently, an
ncreasing number of natural compounds have been found to
xert chemopreventive properties against a wide spectrum of
ancers by involving the Nrf2–ARE signaling pathway. The
hemopreventive activities of cruciferous vegetables have been
ddressed in several epidemiological studies and in animal
odels of chemically induced carcinogenesis [32]. Phenolic
nd sulfur-containing compounds are two major classes of
ietary components that also act as promising chemopreventive
gents. Phenolic compounds, widely distributed in plants, can
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e classified into polyphenols such as epigallocatechin-3-gallate
EGCG) from green tea, curcumin from turmeric, resvera-
rol from grapes, and flavonoids such as quercetin from citrus
ruits and genistein from soybean. Sulfur-containing compounds
an be generally classified into two major categories, namely,
sothiocyanates including sulforaphane (SFN) from broccoli,
henethyl isothiocyanate (PEITC) from turnips and watercress,
s well as allyl isothiocyanate from Brussels sprouts, and
rganosulfur compounds including diallyl sulfides from garlic
il [33].
.1.  Phenolic  compounds
Phenolic compounds are well-known for their anti-
arcinogenic activity in the edible plant kingdom. The molecular
echanisms of polyphenols acting as chemopreventive agents
n vitro  and in  vivo  have been extensively reported [34]. The stim-
lation of phase II detoxifying and antioxidant defense enzymes
hrough Nrf2-signaling pathway has been considered as one
f the critical mechanisms. Representative examples of these
ompounds, including EGCG, quercetin and curcumin, will be
iscussed, respectively.
.1.1.  EGCG
Green tea has attracted much attention for its beneficial
ealth effects. Epidemiological studies have suggested that
he consumption of green tea may reduce the risk of can-
ers. Accumulating evidence from numerous laboratory and
pidemiological studies supports the concept that the consump-
ion of green tea can complete the protective role against the
evelopment of various types of malignancies. EGCG, a puta-
ive chemopreventive agent and the major active catechin in
reen tea, is known to possess anti-oxidant, anti-inflammatory
nd chemopreventive properties. Therefore, EGCG has been
dentified as the most potent Nrf2 activator among green tea
olyphenols due to its ability to induce the transactivation of the
RE-luciferase reporter gene [35]. EGCG has also been reported
o activate Nrf2-mediated HO-1 expression in B lymphoblasts,
pithelial and endothelial cells, and to stimulate the expression
f many Nrf2-dependent genes in the liver and intestines of
ice [36,37]. Similarly, EGCG has been reported to inhibit
ipopolysaccharide-induced pulmonary fibrosis by enhancing
he activities of antioxidant and phase II enzymes such as GST
nd NQO1 mediated by Nrf2–Keap1 signaling [38]. Addition-
lly, the administration of EGCG by gavage can induce the
xpression of HO-1, -glutamyltransferase 1 and the catalytic
ubunit of GCL in an Nrf2-dependent manner, which has been
onfirmed by results demonstrating that EGCG does not induce
he expression of these genes in Nrf2-deficient mice. Another
echanism responsible for EGCG-induced activation of Nrf2
nvolves the phosphorylation of serine/threonine residues of
rf2. For example, EGCG can induce the nuclear localization of
rf2 through the activation of ERK1/2 and the phosphorylation
f Akt in MCF-10A breast cancer and Caco-2 colon cancer cells
39]. It is apparent from these data that the anti-inflammatory
nd anti-oxidative stress capabilities of EGCG can be potentially
n
b
f
rman Wellness 2 (2013) 22–28
tilized for cancer prevention in humans, particularly since
hronic inflammation is correlated with 20% of human cancers.
Chemopreventive effects of EGCG are attributed to mod-
lation of the intracellular signaling network responsible for
roliferation, differentiation, apoptosis, adhesion, angiogene-
is and metastasis associated with carcinogenesis [40,41], and
GCG appears to exert an inhibitory effect on the proliferation
f bovine capillary endothelial cells [42]. In addition, the anti-
ancer activity of EGCG may also reduce metastatic invasion,
he major cause of mortality in cancer patients, by inhibiting the
ctivity of urokinase or matrix metalloproteinases (MMPs), or
y scavenging oxygen free radicals [43]. In human colon HT-29
ancer cells, EGCG treatment results in the damage of mitochon-
ria and apoptosis through the JNK pathway [44]. Angiogenesis
s necessary not only for nourishing the growth of tumors, but
lso for metastasis. Experimental evidence suggests that the
dministration of EGCG in drinking water for TRAMP mice
s associated with the inhibition of tumors due to decreased
xpression of vascular endothelial growth factor (VEGF) and
nhibition of angiogenesis [45]. Another study has also shown
hat EGCG inhibits both the growth of colon tumors, as well as
etastasis through the liver or lungs, in orthotopically implanted
ude mice, which is proposed to be partly due to the modulated
ctivation of the Nrf2–UGT1A signal pathway [46].
.1.2. Resveratrol
Resveratrol, a phytoalexin produced by a wide variety of
lants, particularly in the skin and seeds of red grapes, exhibits
ultiple therapeutic effects, including anti-oxidative and anti-
nflammatory effects as well as chemopreventive activity in
everal types of cancers. It is well known that resveratrol has
een intensively investigated as a promising agent for cancer
revention. Previous reports have demonstrated that resvera-
rol, as a cancer chemopreventive molecule, mainly completes
ts function by triggering apoptosis, which has been confirmed
y resveratrol-mediated cell growth inhibition and apoptosis
nduction in prostate cancer cells [47] as well as the reduced
ncidence of carcinogen-induced carcinogenesis in experimen-
al animals [48]. With respect to corresponding mechanisms,
rf2–Keap1–ARE has attracted much attention. Resveratrol
as been shown to protect against H2O2-induced PC12 cell
eath through the activation of Nrf2 and increased HO-1
xpression [49]. It is also reported to exhibit protective effects
gainst H2O2-induced and -amyloid-induced cell death in rat
heochromocytoma cells by attenuating intracellular ROS accu-
ulation and restoring the level of some marker proteins related
o apoptosis [50,51]. Resveratrol is postulated to function as a
otential signaling pathway modulator and, as such, has demon-
trated its ability to affect a multitude of signal transduction
athways associated with cancer-preventive effects. Resveratrol
lso can cause an arrest at the S/G2 phase transition of the cell
ycle and is capable of inducing differentiation and apoptosis in
 multitude of cancer cell lines, including leukemia, hepatoma,
euroblastoma, prostate cancer, colon cancer, gastric cancer and
reast cancer cells [52]. In a postnatal day 7 rodent model of
etal alcohol spectrum disorders (FASD), the administration of
esveratrol before ethanol exposure can restore the level of Nrf2,
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nd prevent ethanol-induced oxidative stress in the cerebel-
um [53]. In addition, resveratrol exhibits antioxidant properties
y inducing GSH biosynthesis via  the activation of Nrf2, and
rotects lung epithelial cells against cigarette smoke-mediated
xidative stress in human lung epithelial cells [54].
.1.3. Curcumin
Curcumin is a naturally occurring yellow pigment, isolated
rom the rhizomes of the plant Curcuma  longa  (Linn), which
s commonly used in Asian cooking as a coloring and flavor-
ng agent. Studies have shown that curcumin has a wide range
f biological effects, including anti-inflammatory, antioxidant,
hemopreventive and chemotherapeutic activities. As summa-
ized by Hatcher et al., curcumin protects against various types
f carcinomas [55]. Pleiotropic effects of curcumin are derived
rom its ability to affect multiple survival and cytoprotec-
ive signaling pathways, including the pathways that inhibit
nflammatory responses and those regulated by NF-B, AKT,
rowth factors and Nrf2 transcription factor [56]. Curcumin
xerts both direct and indirect antioxidant effects by scav-
nging reactive oxygen species (ROS) [57] and inducing the
xpression of cytoprotective proteins in an Nrf2-dependent way
28]. Curcumin has been shown to induce GSTP1 expression
ith the involvement of transcription factor Nrf2 in human
epatic cells [58]. Pretreatment with curcumin can protect
gainst H2O2-induced cell death by up-regulating HO-1 and
hioredoxin that are mediated by Nrf2 transcription factor in
etina-derived cell lines (661W and ARPE-19) [56]. In addi-
ion, curcumin can activate Nrf2–ARE signaling by stimulating
pstream kinases. For example, curcumin can induce the expres-
ion of HO-1 by a pathway involving the transcription factor
rf2 and PI-3K/Akt-mediated signaling pathway in mouse 
ells. Moreover, curcumin can activate ARE-mediated expres-
ion of antioxidant defense genes in human monocytes via
KC-, p38MAPK and Nrf2 [17].
.2.  Sulfur-containing  compounds
.2.1.  Isothiocyanates
Isothiocyanates (ITCs) are found in cruciferous vegetables
uch as broccoli, Brussels sprouts, cauliflower and cabbage.
ulforaphane (SFN) is a type of ITC found in cruciferous veg-
tables, with particularly higher levels in broccoli and Brussels
prouts. Epidemiological evidence suggests a reduced risk for
rostate, lung, breast and colon cancers for people who consume
ruciferous vegetables [59]. SFN has proven to be an effective
hemoprotective agent in cell cultures, carcinogen-induced and
enetic animal cancer models, as well as in xenograft models of
ancer.
SFN was identified as a chemopreventive agent over a decade
go on the basis of its capability to induce phase II detoxification
nzymes, and to inhibit phase I enzymes involved in the activa-
ion of carcinogens. SFN augments various pathways known
o facilitate carcinogen detoxification and excretion. For exam-
le, mice treated with SFN at a daily dosage of 15 mol/mouse
y gavage for 5 consecutive days exhibited an increase in
uinone reductase (QR) and glutathione-S-transferase (GST) in
i
m
I
pman Wellness 2 (2013) 22–28 25
he liver, forestomach, glandular stomach, proximal small intes-
ine, and lungs [60], suggesting that SFN also can induce phase
I enzymes in  vivo  following oral ingestion. Although many
ell lines reveal a response to SFN in  vitro, the induction and
ype of phase II enzymes reveal variations dependent on the
ifferent cell types. In human HepG2 cells, SFN up-regulates
RNA expression of UDP-glucuronosyltranferase (UGT) 1A1
nd GSTA1 [61,62]. Similarly, upon treatment with SFN, a sig-
ificant increase in GST and QR activities is also observed in
urine Hepa1c1c7 cells and human prostate cells, although, an
pparent decrease in GST activity in HT29 cells has also been
eported [63,64]. Importantly, the effects of SFN in cell cultures
an be extrapolated to in  vivo  situations. In  vivo  experiments
ave demonstrated the SFN-induced increase in QR and GST
ctivities in the liver, colon and pancreas [65]. Moreover, oral
reatment with SFN increases the gene expression of phase II
ntioxidant enzymes such as GSTM1, GSTP1, NQO1, and HO-
 in the human upper respiratory tract [66]. Additionally, the
nduction effects of SFN on cell cycle arrest and/or apoptosis
ave also been explored and confirmed in different experiments.
n HT-29 human colon cancer cells, treatment with 100 M SFN
or 24 or 48 h can result in a decrease in cell viability [67],
 decrease in the population of the cells in G1 phase and an
ncrease in the population in G2/M phase, as well as an obvious
ncrease in protein levels of cyclin A and cyclin B1 [68].
In recent years, two major mechanisms have been proposed
o explain the induction of phase II enzymes by SFN. One is
he disruption of Nrf2–Keap1 interaction and the other is the
ctivation of mitogen-activated protein kinase (MAPK). The dis-
uption of Nrf2–Keap1 interaction, translocation of Nrf2 to the
ucleus, and induction of ARE-associated genes due to the appli-
ation of SFN have been extensively discussed. The importance
f Nrf2 is illustrated through Nrf2 knockout mice, in which the
esponse to SFN in the induction of the aforementioned genes
s abrogated. Conversely, SFN can activate ARE-driven genes
y activating the MAPK pathway, however, the application of
APK inhibitors can significantly attenuate QR activity and
RE reporter activity in HepG2 cells [69].
.2.2. Diallyl  sulﬁde
Garlic is a bulbous root with a strong taste and smell. Dial-
yl sulfide (DAS) is a flavor compound derived from garlic
nd is sequentially converted to diallyl sulfoxide (DASO) and
iallyl sulfone (DASO2) by cytochrome P4502E1 (CYP2E1).
pidemiological and animal studies have shown that frequent
onsumption of garlic and other allium vegetables may be asso-
iated with decreased incidence of gastric, chemical-induced
kin, cervical, forestomach, lung, colon and esophageal cancers
70].
Research over the years has revealed that the chemo-
reventive activity of garlic targets multiple pathways to inhibit
he growth of cancer cells via  carcinogen metabolism impair-
ent, cell cycle arrest, apoptosis induction, and angiogenesis
nhibition. It is well known that allyl sulfur compounds can
odulate drug metabolism systems, especially different phase
I detoxifying enzymes. DAS has also been shown to inhibit
hase I enzymes and induce phase II enzymes such as GST-,
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ST-  and GST-  in rat liver [71,72]. Another study has also
escribed the roles of DAS in the expression of ARE-mediated
enes and Nrf2, NQO1 and HO-1 proteins [73]. Wattenberg
nd colleagues have demonstrated that organosulfur compounds
OSCs) in garlic may prevent benzopyrene-induced forestom-
ch and lung cancers in mice, and this process is accompanied
y observed elevation of hepatic and target organ glutathione
ransferase activity [74]. One recent study has shown that DAS
an cause a striking increase in GSTMu2 and epoxide hydro-
ase [75]. Collectively, these investigations suggest that OSCs
an execute preventive functions for chemical-induced cancers
ot only by inhibiting the activation of carcinogens, but also by
nhancing the detoxification of activated carcinogenic interme-
iates through the induction of phase II enzymes.
Currently, the underlying mechanism of DAS on the induc-
ive effect of phase II enzymes is still unclear although several
ypotheses have been proposed. Extensive studies have demon-
trated that diallyl sulfides could induce drug-metabolizing
nzymes such as NQO1 and HO-1 in an Nrf2/ARE-dependent
anner because DATS-induced expression of several detoxify-
ng enzyme genes is observed in wild-type mice, but not in Nrf2
nockout mice [76]. Similarly, other investigators have reported
hat DAS can induce HO-1 through the production of ROS that
s mediated by Nrf2 and MAPK.
.2.3. Others
Other natural chemopreventive agents that may induce phase
I detoxifying enzymes through the Nrf2/ARE pathway include
ithiolethiones and anethole dithiolethione. Dithiolethione has
een reported to exert chemopreventive properties in the lung,
olon and liver. Similarly, dithiolethiones appear to exhibit
hemopreventive activity against aflatoxin-mediated hepato-
arcinogenesis [77].
.  Conclusion
Two classes of potential natural chemopreventive agents as
escribed in this review have been extensively studied and many
ther compounds are under investigation for their regulation
f this protective mechanism. Gaining a better understanding
f the molecular mechanisms associated with these compounds
ill provide beneficial guidance for developing new strategies
n cancer prevention. An increasing body of evidence supports
he premise that the Nrf2/ARE pathway plays a critical role
n the protective mechanism of cells through the induction of
hase II detoxifying and antioxidant enzymes. Thus, the iden-
ification of factors influencing the Nrf2 pathway provides new
nsight into fighting cancers. Natural compounds represent an
ffective and rational strategy for cancer prevention due to their
bility to induce the expression of phase II detoxification via
rf2–ARE pathway, as well as their relatively low toxicity, low
ost and resource abundance. Due to the structural diversity
mong these chemopreventive agents targeting the Nrf2/ARE
ignaling pathway and the complexity of the upstream cellular
ignaling events, substantial research is still needed to elucidate
he complex regulation of the Nrf2/ARE signal transduction
athway. Moreover, most investigations of natural products
[man Wellness 2 (2013) 22–28
re focused on in  vitro  experiments, but the improved under-
tanding of the roles of natural products in chemoprevention
ill necessarily include data from in  vivo  studies in future,
s well.
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